Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IL23A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | RNF5 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | PACSIN3 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
mRNA | AGO3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | SERPINB3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | CDC42BPG | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | TEAD3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | IL1A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | GNA11 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | KRT6B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |